Results 261 to 270 of about 368,090 (311)

Prehabilitation as a Biologically Active Intervention Is Associated with the Remodeling of the Pancreatic Tumor-Immune Microenvironment. [PDF]

Int J Mol Sci
Stubbins R, Li B, Vasquez M, Gorman BK, Zambelas J, Allenson K, Dhala A, Dong W, Zhao H, Wong S.   +9 more
europepmc   +1 more source

Aptamer‐Engineered Liposomal Platform Enables in Situ cDC1 Vaccination to Potentiate Immunotherapy in Prostate Cancer

Advanced Science, EarlyView.
Prostate cancer is immunologically ‘cold’, with scarce, dysfunctional type 1 conventional dendritic cells (cDC1s) that limit T cell priming. We introduce an aptamer‐targeted liposomedelivering FMS‐like tyrosine kinase 3 ligand (Flt3L) and chlorin e6 (Ce6). Ultrasound induces antigen release and cDC1s recruitment, creating an in situ cDC1 vaccine.
Jiayi Wang, Xuan Wang, Xinfeng Dai, Linxin Tian, Wencheng Shen, Xueliang Liu, Wei Xue, Jiahua Pan, Yu Yang   +8 more
wiley   +1 more source

Tumor immune microenvironment states inferred from TLS-associated immune-cell composition stratify prognosis in hepatocellular carcinoma. [PDF]

Front Immunol
Cheng C, Chen G, Zhang J, Qiu L, Li Z, Dong X, Lu C, Wu Q, Peng X, Cai Z, Zeng Y.   +10 more
europepmc   +1 more source

<i>CREM</i> regulates the tumor immune microenvironment and predicts prognosis in thyroid carcinoma. [PDF]

Transl Cancer Res
Ling H, Wu G, Tang L, Hu Y.
europepmc   +1 more source

Hydrogel-Based Immunomodulation of Tumor Immune Microenvironment in Hepatocellular Carcinoma: Current Strategies and Future Directions. [PDF]

Int J Nanomedicine
Zhang S, Ding L, Hou T, Lin D, Qu Y.
europepmc   +1 more source

Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes. [PDF]

Oncoimmunology
Torland LA, Geisler J, Azimzade Y, Frafjord A, Røed Nilsen H, Buer L, Lømo J, Garred Ø, Tahiri A, Lyngra M, Øynebråten I, Corthay A, Sahlberg K, Kristensen V, Tekpli X.   +14 more
europepmc   +1 more source

Irreversible electroporation in prostate cancer: efficacy, tumor immune microenvironment remodeling, and combination immunotherapy-a narrative review. [PDF]

Transl Androl Urol
Xiao J, Lv Z, Zhang Z, Wei H, Jiang X, Tian J.   +5 more
europepmc   +1 more source

Combination of APS, HMGN1, and anti-TNFR2 antibody remodels the tumor immune microenvironment to enhance antitumor immunity in colorectal cancer. [PDF]

Transl Oncol
Zhao L, Pei X, Wu H, Zhou S, Song J, Wan Q, Lv H, Xu J, Nie Y.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immune checkpoints in the tumor microenvironment

Seminars in Cancer Biology, 2020
Interactions between immune checkpoints (ICs) and their ligands negatively regulate T cell activation pathways involved in physiological immune responses against specific antigens. ICs and their ligands are frequently upregulated in the tumor microenvironment (TME) of various malignancies, and they represent significant barriers for induction of ...
Salman M Toor, Varun Sasidharan Nair, Julie Decock   +2 more
exaly   +3 more sources